Howard Bergman

Professor and Scientific Director
McGill University

Howard Bergman, MD, is Chair of the Department of Family Medicine, Professor of Family Medicine, Medicine, and Oncology, and the first Dr. Joseph Kaufmann Professor of Geriatric Medicine at McGill University. From 2009 to 2011, Dr. Bergman served as Vice-President, Scientific Affairs of the Fonds de la recherche en santé du Québec (FRSQ), Quebec’s health research funding agency. He is an investigator at Solidage: the McGill University/Université de Montréal Research Group on Frailty and Aging, as well as at the Bloomfield Centre for Research on Aging at the Lady Davis Institute, Jewish General Hospital. He is Adjunct Professor in the Department of Health Administration, Université de Montréal, and Invited Professor in the Faculty of Medicine, Université de Lausanne in Switzerland. He is also adjunct full Professor in the Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel. From 1993 to 2009, he was Director of the Division of Geriatric Medicine at McGill University and the Jewish General Hospital.

Dr. Bergman is a Fellow of the Canadian Academy of Health Sciences (CAHS). He is a past President of the Canadian Geriatrics Society which awarded him the Ronald Cape Distinguished Service Award, a past Scientific Director of the FRSQ Quebec Network for Research in Aging, a past President of the Consortium of Canadian Centers for Clinical Cognitive Research (C5R) and a past Chair of the Advisory Board of the Institute of Ageing of the Canadian Institutes of Health Research (CIHR). In 2000-2001, Dr. Bergman was a member of the “Clair Commission,” an independent commission set up by the Quebec government to propose reforms to the health care system. Appointed by the Quebec Minister of Health in 2007, Dr. Bergman tabled, in 2009, a proposal for the Quebec Alzheimer Plan, from prevention to end of life care, including the research agenda. Dr. Bergman was recently elected Chair of the Board of Directors of AllerGen, the Canadian Allergy, Genes and Environment Network and is a member of the Board of Directors of the Institute for Research on Public Policy. He serves as consultant to Regional Health Boards and ministries of health in Canada and other countries as well as to industry.

Back